Skip to main content

Advertisement

Log in

Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Purpose

Data on purpura fulminans (PF) in adult patients are scarce and mainly limited to meningococcal infections. Our aim has been to report the clinical features and outcomes of adult patients admitted in the intensive care unit (ICU) for an infectious PF, as well as the predictive factors for limb amputation and mortality.

Methods

A 17-year national multicenter retrospective cohort study in 55 ICUs in France from 2000 to 2016, including adult patients admitted for an infectious PF defined by a sudden and extensive purpura, together with the need for vasopressor support. Primary outcome variables included hospital mortality and amputation during the follow-up period (time between ICU admission and amputation, death or end of follow-up).

Results

Among the 306 included patients, 126 (41.2%; 95% CI 35.6–46.9) died and 180 (58.8%; 95% CI 53.3–64.3) survived during the follow-up period [13 (3–24) days], including 51/180 patients (28.3%, 95% CI 21.9–35.5) who eventually required limb amputations, with a median number of 3 (1–4) limbs amputated. The two predominantly identified microorganisms were Neisseria meningitidis (63.7%) and Streptococcus pneumoniae (21.9%). By multivariable Cox model, SAPS II [hazard-ratio (HR) = 1.03 (1.02–1.04); p < 0.001], lower leucocytes [HR 0.83 (0.69–0.99); p = 0.034] and platelet counts [HR 0.77 (0.60–0.91); p = 0.007], and arterial blood lactate levels [HR 2.71 (1.68–4.38); p < 0.001] were independently associated with hospital death, while a neck stiffness [HR 0.51 (0.28–0.92); p = 0.026] was a protective factor. Infection with Streptococcus pneumoniae [sub-hazard ratio 1.89 (1.06–3.38); p = 0.032], together with arterial lactate levels and ICU admission temperature, was independently associated with amputation by a competing risks analysis.

Conclusion

Purpura fulminans carries a high mortality and morbidity. Pneumococcal PF leads to a higher risk of amputation.

Trials registration

NCT03216577.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Vincent JL, Nadel S, Kutsogiannis DJ, Gibney RT, Yan SB, Wyss VL, Bailey JE, Mitchell CL, Sarwat S, Shinall SM, Janes JM (2005) Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care 9:R331–R343

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lerolle N, Carlotti A, Melican K, Aubey F, Pierrot M, Diehl JL, Caille V, Hekimian G, Gandrille S, Mandet C, Bruneval P, Dumenil G, Borgel D (2013) Assessment of the interplay between blood and skin vascular abnormalities in adult purpura fulminans. Am J Respir Crit Care Med 188:684–692

    Article  PubMed  Google Scholar 

  3. Fitzgerald CJ, Pranikoff TV, Ross GA, Mou S, Givner LB, Shetty AK (2011) Purpura fulminans caused by community-associated methicillin-resistant Staphylococcus aureus. Am J Emerg Med 30(1013):e1011–e1014

    Google Scholar 

  4. Kravitz GR, Dries DJ, Peterson ML, Schlievert PM (2005) Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 40:941–947

    Article  PubMed  Google Scholar 

  5. Renaud C, Ovetchkine P, Bortolozzi P, Saint-Cyr C, Tapiero B (2010) Fatal group A Streptococcus purpura fulminans in a child receiving TNF-alpha blocker. Eur J Pediatr 170:657–660

    Article  PubMed  Google Scholar 

  6. Giraud T, Dhainaut JF, Schremmer B, Regnier B, Desjars P, Loirat P, Journois D, Lanore JJ (1991) Adult overwhelming meningococcal purpura. A study of 35 cases, 1977–1989. Arch Intern Med 151:310–316

    Article  PubMed  CAS  Google Scholar 

  7. Maat M, Buysse CM, Emonts M, Spanjaard L, Joosten KF, de Groot R, Hazelzet JA (2007) Improved survival of children with sepsis and purpura: effects of age, gender, and era. Crit Care 11:R112

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kornelisse RF, Hazelzet JA, Hop WC, Spanjaard L, Suur MH, van der Voort E, de Groot R (1997) Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score. Clin Infect Dis 25:640–646

    Article  PubMed  CAS  Google Scholar 

  9. Derkx B, Wittes J, McCloskey R (1999) Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group. Clin Infect Dis 28:770–777

    Article  PubMed  CAS  Google Scholar 

  10. Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, Harnden A, Mant D, Levin M (2006) Clinical recognition of meningococcal disease in children and adolescents. Lancet 367:397–403

    Article  PubMed  Google Scholar 

  11. White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP (2000) An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 96:3719–3724

    PubMed  CAS  Google Scholar 

  12. Levin M, Quint PA, Goldstein B, Barton P, Bradley JS, Shemie SD, Yeh T, Kim SS, Cafaro DP, Scannon PJ, Giroir BP (2000) Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 356:961–967

    Article  PubMed  CAS  Google Scholar 

  13. Rintala E, Kauppila M, Seppala OP, Voipio-Pulkki LM, Pettila V, Rasi V, Kotilainen P (2000) Protein C substitution in sepsis-associated purpura fulminans. Crit Care Med 28:2373–2378

    Article  PubMed  CAS  Google Scholar 

  14. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963

    Article  PubMed  Google Scholar 

  15. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710

    Article  PubMed  CAS  Google Scholar 

  16. Zeerleder S, Stephan F, Emonts M, de Kleijn ED, Esmon CT, Varadi K, Hack CE, Hazelzet JA (2012) Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C. Crit Care Med 40:3224–3229

    Article  PubMed  CAS  Google Scholar 

  17. Hazelzet JA (2005) Diagnosing meningococcemia as a cause of sepsis. Pediatr Crit Care Med 6:S50–S54

    Article  PubMed  Google Scholar 

  18. Guiddir T, Gros M, Hong E, Terrade A, Denizon M, Deghmane AE, Taha MK (2018) Unusual initial abdominal presentations of invasive meningococcal disease. Clin Infect Dis. https://doi.org/10.1093/cid/ciy257

    Article  PubMed  Google Scholar 

  19. Theilacker C, Ludewig K, Serr A, Schimpf J, Held J, Bogelein M, Bahr V, Rusch S, Pohl A, Kogelmann K, Frieseke S, Bogdanski R, Brunkhorst FM, Kern WV (2016) Overwhelming postsplenectomy infection: a prospective multicenter cohort study. Clin Infect Dis 62:871–878

    Article  PubMed  Google Scholar 

  20. Cartwright KA (1999) Early management of meningococcal disease. Infect Dis Clin N Am 13:661–684 (viii)

    Article  CAS  Google Scholar 

  21. Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, Moraga-Llop FA, Marco F, Vazquez J, Saez-Nieto JA, Casal J, Canela J, Foz M (1999) Meningococcal disease in a large urban population (Barcelona, 1987–1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance Group. Arch Intern Med 159:2329–2340

    Article  PubMed  CAS  Google Scholar 

  22. Cartwright K, Reilly S, White D, Stuart J (1992) Early treatment with parenteral penicillin in meningococcal disease. BMJ 305:143–147

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Sorensen HT, Nielsen GL, Schonheyder HC, Steffensen FH, Hansen I, Sabroe S, Dahlerup JF, Hamburger H, Olsen J (1998) Outcome of pre-hospital antibiotic treatment of meningococcal disease. J Clin Epidemiol 51:717–721

    Article  PubMed  CAS  Google Scholar 

  24. Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, Bellamy SL, Christie JD (2009) Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 37:1670–1677

    Article  PubMed  CAS  Google Scholar 

  25. Periappuram M, Taylor MR, Keane CT (1995) Rapid detection of meningococci from petechiae in acute meningococcal infection. J Infect 31:201–203

    Article  PubMed  CAS  Google Scholar 

  26. van Deuren M, van Dijke BJ, Koopman RJ, Horrevorts AM, Meis JF, Santman FW, van der Meer JW (1993) Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions. BMJ 306:1229–1232

    Article  PubMed  PubMed Central  Google Scholar 

  27. de Risi-Pugliese T, Servy A, Decousser JW, Nebbad B, Desroches M, Wolkenstein P, de Prost N, Chosidow O (2017) Skin biopsy polymerase chain reaction for rapid microbiological diagnosis in patients with purpura fulminans. Br J Dermatol 177:e154–e155

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

List of the members of the Hopeful Study Group: Laurent Argaud (Lyon), François Barbier (Orléans), Amélie Bazire (Brest), Gaëtan Béduneau (Rouen), Frédéric Bellec (Montauban), Pascal Beuret (Roanne), Pascal Blanc (Pontoise), Cédric Bruel (Saint-Joseph), Christian Brun-Buisson (Mondor, AP-HP), Gwenhaël Colin (La Roche-sur-Yon), Delphine Colling (Roubaix), Alexandre Conia (Chartres), Rémi Coudroy (Poitiers), Martin Cour (Lyon), Damien Contou (Henri Mondor—AP-HP and Argenteuil), Fabrice Daviaud (Corbeil-Essonnes), Vincent Das (Montreuil), Jean Dellamonica (Nice), Nadège Demars (Antoine Beclère, AP-HP), Stephan Ehrmann (Tours), Arnaud Galbois (Quincy sous Sénart), Elodie Gelisse (Reims), Julien Grouille (Blois), Laurent Guérin (Ambroise Paré—AP-HP), Emmanuel Guérot (HEGP, AP-HP), Samir Jaber (Montpellier), Caroline Jannière-Nartey (Créteil), Sébastien Jochmans (Melun), Mathieu Jozwiak (Kremlin Bicêtre, AP-HP), Pierre Kalfon (Chartres), Antoine Kimmoun (Nancy), Alexandre Lautrette (Clermont Ferrand), Jérémie Lemarié (Nancy), Charlène Le Moal (Le Mans), Christophe Lenclud (Mantes La Jolie), Nicolas Lerolle (Angers), Olivier Leroy (Tourcoing), Antoine Marchalot (Dieppe), Bruno Mégarbane (Lariboisière, AP-HP), Armand Mekontso Dessap (Mondor, AP-HP), Etienne de Montmollin (Saint-Denis), Frédéric Pène (Cochin, AP-HP), Claire Pichereau (Poissy), Gaëtan Plantefève (Argenteuil), Sébastien Préau (Lille), Gabriel Preda (Saint-Antoine, AP-HP), Nicolas de Prost (Henri Mondor, AP-HP), Jean-Pierre Quenot (Dijon), Sylvie Ricome (Aulnay-sous-Bois), Damien Roux (Louis Mourier, AP-HP), Bertrand Sauneuf (Cherbourg), Matthieu Schmidt (Pitié Salpétrière, AP-HP), Guillaume Schnell (Le Havre), Romain Sonneville (Bichat, AP-HP), Jean-Marc Tadié (Rennes), Yacine Tandjaoui (Avicenne, AP-HP), Martial Tchir (Villeneuve Saint Georges), Nicolas Terzi (Grenoble), Xavier Valette (Caen), Lara Zafrani (Saint-Louis, AP-HP), Benjamin Zuber (Versailles).

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Damien Contou.

Ethics declarations

Conflicts of interest

This study received a financial support of the Fondation de France (#0069110). The authors have not disclosed any potential conflicts of interest.

Additional information

The members of the Hopeful Study Group are listed in “Acknowledgements” section.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 57 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Contou, D., Sonneville, R., Canoui-Poitrine, F. et al. Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study. Intensive Care Med 44, 1502–1511 (2018). https://doi.org/10.1007/s00134-018-5341-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-018-5341-3

Keywords

Navigation